4-Methylphenol (p-Cresol) (p-Cresol)

p-Cresol (4-methylphenol) is a phenolic compound primarily produced by the anaerobic fermentation of aromatic amino acids, such as tyrosine and phenylalanine, by gut bacteria (PubChem CID 289; Gryp et al., 2017). In the human body, it is rapidly conjugated in the liver and intestines to form p-cresyl sulfate and p-cresyl glucuronide, which are classified as protein-bound uremic toxins (Meijers et al., 2010). These metabolites accumulate significantly in patients with impaired renal function, particularly those with chronic kidney disease (CKD). High systemic levels of p-cresol derivatives are linked to the progression of renal damage, vascular calcification, and increased cardiovascular mortality due to their ability to induce oxidative stress and systemic inflammation (Lin et al., 2015). Because p-cresol is a small molecule metabolite rather than a protein, it is not a traditional drug target such as a receptor or enzyme. However, it is a significant target for removal or reduction strategies in the context of renal failure. Therapeutic approaches focus on the use of oral adsorbents like AST-120 to sequester the molecule in the gut or the modulation of gut microbiota to decrease its production (Niwa, 2011). A major challenge in managing p-cresol levels is its high affinity for albumin, which makes it difficult to remove through conventional hemodialysis.

Other names

4-methylphenolpara-cresol1-hydroxy-4-methylbenzenep-methylphenol4-hydroxytoluene

Adsorption of the metabolite in the gastrointestinal tract to prevent systemic absorption